Microsoft (NasdaqGS:MSFT) reported that its threat intelligence teams helped uncover a Beijing-backed AI-driven cyber campaign targeting multiple sensitive sectors in 2026. The company disclosed that attackers used generative AI tools to craft spear-phishing content and automate reconnaissance against government, defense and telecom organizations. Microsoft also announced a new collaboration with Boehringer Ingelheim to use Azure-powered AI "digital patient twins" in clinical trials and drug development. These AI-driven cyberattacks and the Boehringer Ingelheim digital patient twin project matter, but investors need a wider view of Microsoft. Check out 3 other big wins that Microsoft investors should know about.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.